These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21134363)

  • 1. Cytotoxic effects of new trans-2,4-diaryl-r-3-methyl-1,2,3,4-tetrahydroquinolines and their interaction with antitumoral drugs gemcitabine and paclitaxel on cellular lines of human breast cancer.
    Muñoz A; Sojo F; Arenas DR; Kouznetsov VV; Arvelo F
    Chem Biol Interact; 2011 Feb; 189(3):215-21. PubMed ID: 21134363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.
    Konecny G; Untch M; Slamon D; Beryt M; Kahlert S; Felber M; Langer E; Lude S; Hepp H; Pegram M
    Breast Cancer Res Treat; 2001 Jun; 67(3):223-33. PubMed ID: 11561768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling.
    Oliveras-Ferraros C; Vazquez-Martin A; Colomer R; De Llorens R; Brunet J; Menendez JA
    Int J Oncol; 2008 Jan; 32(1):113-20. PubMed ID: 18097549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines.
    Teixidó C; Arguelaguet E; Pons B; Aracil M; Jimeno J; Somoza R; Marés R; Ramón Y Cajal S; Hernández-Losa J
    Int J Oncol; 2012 Jul; 41(1):317-24. PubMed ID: 22485250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines.
    Edelman MJ; Quam H; Mullins B
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):141-4. PubMed ID: 11561780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
    Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
    Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma.
    Voigt W; Kegel T; Weiss M; Mueller T; Simon H; Schmoll HJ
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):585-90. PubMed ID: 16021466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.
    Mu Q; Yu J; Griffin JI; Wu Y; Zhu L; McConnachie LA; Ho RJY
    PLoS One; 2020; 15(3):e0228557. PubMed ID: 32142553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.
    Larson N; Yang J; Ray A; Cheney DL; Ghandehari H; Kopeček J
    Int J Pharm; 2013 Sep; 454(1):435-43. PubMed ID: 23827653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic.
    Papa AL; Sidiqui A; Balasubramanian SU; Sarangi S; Luchette M; Sengupta S; Harfouche R
    Cell Oncol (Dordr); 2013 Dec; 36(6):449-57. PubMed ID: 24081907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells.
    Ma L; Wei J; Su GH; Lin J
    Cancer Biol Ther; 2019; 20(6):855-865. PubMed ID: 30866697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.
    Pegram MD; Konecny GE; O'Callaghan C; Beryt M; Pietras R; Slamon DJ
    J Natl Cancer Inst; 2004 May; 96(10):739-49. PubMed ID: 15150302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
    Budman DR; Calabro A
    Oncology; 2006; 70(2):147-53. PubMed ID: 16645328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
    ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity.
    Loprevite M; Favoni RE; de Cupis A; Pirani P; Merlo F; Grossi F; Ardizzoni A
    Int J Oncol; 1999 Oct; 15(4):787-92. PubMed ID: 10493963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.
    Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of the antitumoral activity of gemcitabine and paclitaxel in combination on human breast cancer cells.
    Zupi G; Scarsella M; D'Angelo C; Biroccio A; Paoletti G; Lopez M; Leonetti C
    Cancer Biol Ther; 2005 Aug; 4(8):866-71. PubMed ID: 16210917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells.
    Shafaee Z; Schmidt H; Du W; Posner M; Weichselbaum R
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):765-70. PubMed ID: 16552573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo.
    O'Reilly T; McSheehy PM; Wartmann M; Lassota P; Brandt R; Lane HA
    Anticancer Drugs; 2011 Jan; 22(1):58-78. PubMed ID: 20890178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody fragment-conjugated gemcitabine and paclitaxel-based liposome for effective therapeutic efficacy in pancreatic cancer.
    Yang W; Hu Q; Xu Y; Liu H; Zhong L
    Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():328-335. PubMed ID: 29752104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.